Gustavo D Heresi (Gustavo A Heresi)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Pulmonary Arterial Hypertension

Cross Sectional

Cardiovascular Disease

Direct Oral Anticoagulants

Top Venues

Pulmonary circulation

Annals of the American Thoracic Society

Journal of thrombosis and thrombolysis

JPEN. Journal of parenteral and enteral nutrition

This page only lists publications with an associated author ORCID identifier.

Publications

Oisín Butler, Shinyoung Ju, Soeren Hoernig, Kai Vogtländer, Sameer Bansilal, Gustavo D Heresi
Assessment for residual disease after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension. ERJ open research 8 (2) (2022)
Jacob T Mey, Mary C Rath, Kathleen McLaughlin, Marianne Galang, Kathryn Lynch, Jaime DiMattio, Hillary Nason, Shengping Yang, Celia A Melillo, David E Grove, Adriano R Tonelli, Gustavo D Heresi, John P Kirwan, Raed A Dweik
The breath print represents a novel biomarker of malnutrition in pulmonary arterial hypertension: A proof of concept study. JPEN. Journal of parenteral and enteral nutrition 45 (8) (2021)
Ghaleb Khirfan, Manshi Li, Xiaofeng Wang, Joseph A DiDonato, Raed A Dweik, Gustavo D Heresi
Abnormal levels of apolipoprotein A-I in chronic thromboembolic pulmonary hypertension. Pulmonary circulation 11 (2) (2021)
Mateo Porres-Aguilar, Marius M Hoeper, Belinda N Rivera-Lebron, Gustavo D Heresi, Debabrata Mukherjee, Victor F Tapson
Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension. Journal of thrombosis and thrombolysis 52 (3) (2021)
Nils Patrick Nickel, Gian M Galura, Marc J Zuckerman, M Nawar Hakim, Haider Alkhateeb, Debabrata Mukherjee, Eric D Austin, Gustavo D Heresi
Liver abnormalities in pulmonary arterial hypertension. Pulmonary circulation 11 (4) (2021)
Samar Farha, Gustavo D Heresi
COVID-19 and Pulmonary Arterial Hypertension: Early Data and Many Questions. Annals of the American Thoracic Society 17 (12) (2020)
Gustavo D Heresi, Youlan Rao
Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial Hypertension. Lung 198 (6) (2020)